Post by Deb on Dec 22, 2005 19:20:41 GMT -5
Lannett Company Receives Approval for Baclofen Tablets
PHILADELPHIA--(BUSINESS WIRE)----Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Baclofen 20mg tablets. According to NDC Health, total annual sales of Baclofen in 2004 were $89.5 million. Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
The approval brings to nine the total Lannett ANDA's approved by the FDA in the last seven months. "We are grateful to our employees for their hard work and dedication in bringing about these results," said Arthur Bedrosian, president of Lannett. "We have been very active this year in expanding our product offerings and will look to maintain this momentum in the coming year."
About Lannett Company:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company's website at www.lannett.com.
PondelWilkinson Inc. Robert Jaffe/Wade Huckabee, 310-279-5980
12/22/2005 07:45 ET
PHILADELPHIA--(BUSINESS WIRE)----Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Baclofen 20mg tablets. According to NDC Health, total annual sales of Baclofen in 2004 were $89.5 million. Baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
The approval brings to nine the total Lannett ANDA's approved by the FDA in the last seven months. "We are grateful to our employees for their hard work and dedication in bringing about these results," said Arthur Bedrosian, president of Lannett. "We have been very active this year in expanding our product offerings and will look to maintain this momentum in the coming year."
About Lannett Company:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. For more information, visit Lannett Company's website at www.lannett.com.
PondelWilkinson Inc. Robert Jaffe/Wade Huckabee, 310-279-5980
12/22/2005 07:45 ET